文献速递临床试验与 GCP

曲唑酮、褪黑素及联合治疗用于创伤性脑损伤后失眠、疲劳和日间嗜睡:随机临床试验研究方案

Trazodone, melatonin, and combination therapy for insomnia, fatigue, and daytime sleepiness following traumatic brain injury: study protocol for a randomized clinical trial.
PubMed 文献 · Trials · 2026-05-21

recruitment仍在进行中。

要点

  • 比较曲唑酮、褪黑素及联合治疗对TBI后失眠、疲劳和日间嗜睡的疗效。
  • 纳入标准为GCS评分3-12且ISI≥8的中重度TBI成人。
  • 治疗4周,主要结局为ISI、FSS和ESS评分变化。

核心结论

  • 该研究旨在比较曲唑酮、褪黑素及联合治疗对TBI患者失眠、疲劳和日间嗜睡的效果。

研究设计与样本

  • 按1:1:1随机分配至曲唑酮组(25-100 mg/晚)、褪黑素组(3-5 mg/晚)或联合组,治疗4周。

主要发现

  • 研究尚未报告结果,招募正在进行中。

关键数值与推荐

  • 失眠严重指数(ISI)≥8作为失眠纳入标准。
  • 格拉斯哥昏迷量表(GCS)评分3-12定义为中度至重度TBI。
  • 曲唑酮剂量范围25-100 mg/晚,褪黑素剂量范围3-5 mg/晚。
  • 主要结局为治疗前后ISI、疲劳严重度量表(FSS)和Epworth嗜睡量表(ESS)评分变化。

临床怎么用

  • 目前尚无证据支持曲唑酮或褪黑素在TBI后失眠、疲劳和日间嗜睡中的优劣,临床决策需等待试验结果。

局限性

  • 原文未报告样本量计算的依据及统计把握度。
  • 原文未报告研究的具体局限性,因结果尚未公布。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Sleep problems are common and disabling after traumatic brain injury (TBI). They negatively affect cognitive recovery, emotions, and overall quality of life. Fatigue and excessive daytime sleepiness are also frequent and significantly impair daily functioning. Although trazodone and melatonin are used off-label, we still do not know which works better or if they are more effective together for improving sleep quality, fatigue, and daytime sleepiness in TBI patients. This randomized, double-blind clinical trial aims to compare the effectiveness of trazodone, melatonin, and their combination for improving sleep quality, fatigue severity, and daytime sleepiness in adults with moderate to severe TBI. METHODS: Forty-eight adults with moderate to severe TBI (Glascow Coma Scale (GCS) score of 3-12) and insomnia (insomnia severity index score (ISI) ≥ 8) will be randomly assigned (1:1:1) to receive nightly trazodone (25-100 mg), melatonin (3-5 mg), or both for 4 weeks. Changes in sleep quality (Insomnia Severity Index, ISI), fatigue severity (fatigue severity scale, FSS), and daytime sleepiness (Epworth sleepiness scale, ESS) will be assessed before and after treatment. Recruitment is ongoing. The data will be analyzed via mixed-design ANOVA, with suitable post hoc tests and nonparametric alternatives if the assumptions are not met. DISCUSSION: This study is one of the first to compare trazodone and melatonin alone and in combination for insomnia, fatigue, and daytime sleepiness in TBI patients. The results will help improve treatment strategies for managing sleep problems, fatigue, and daytime sleepiness in individuals with traumatic brain injury. TRIAL REGISTRATION: Iranian Registry of Clinical Trials (IRCT) IRCT20241121063793N1. Registered on December 28, 2024.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Gharooee Ahangar S, Hasanpour M, Fatahian R, et al. Trazodone, melatonin, and combination therapy for insomnia, fatigue, and daytime sleepiness following traumatic brain injury: study protocol for a randomized clinical trial. Trials. 2026. PMID: 42163386. doi:10.1186/s13063-026-09615-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。